Bristol Offers to Buy ImClone for $60 a Share

July 30, 2008

Bristol-Myers Squibb Co. has offered to buy ImClone Systems Inc. for $60 a share, valuing its biotech partner at $5.2 billion, in a deal that would give it greater control of the cancer drug Erbitux.

*For more on this story,

read the full Reuters article.

Want more from the best local business newspaper in the country?

Sign-up for our FREE Daily eNews update to get the latest Orange County news delivered right to your inbox!

Would you like to subscribe to Orange County Business Journal?

One-Year for Only $99

Unlimited access to OCBJ.com
Daily OCBJ Updates delivered via email each weekday morning
Journal issues in both print and digital format
The annual Book of Lists: industry of Orange County's leading companies
Special Features: OC's Wealthiest, OC 500, Best Places to Work, Charity Event Guide, and many more!

Standard Pacific Posts $248M Q2 Loss

Exxon has Record Profit Again on Soaring Oil Prices

staff-author

Bristol Offers to Buy ImClone for $60 a Share

Want more from the best local business newspaper in the country?

Would you like to subscribe to Orange County Business Journal?

Featured Articles

Delaware Court Sides with Joe Kiani in Severance Fight

Masimo Data Backs Pulse Ox Accuracy in Newborns Across All Skin Tones

Midday Stock Roundup: St. John Parent Lanvin Falls Before Earnings

Related Articles

Delaware Court Sides with Joe Kiani in Severance Fight

Masimo Data Backs Pulse Ox Accuracy in Newborns Across All Skin Tones

Midday Stock Roundup: St. John Parent Lanvin Falls Before Earnings

Irvine Industrial Building Trades for $107M

Clean Energy Technologies Gets Non-Compliance Nasdaq Notice

Advertise With Us

About Us

Subscriber Links

Other Journals